The global Arrhythmia Monitoring Devices market size is expected to be worth around US$ 9.41 billion by 2030, according to a new report by Vision Research Reports.
The global Arrhythmia Monitoring Devices market size was valued at US$ 5.98 billion in 2020 and is anticipated to grow at a CAGR of 7.8% during forecast period 2021 to 2030.
Growth Factors
Continuous R&D activities in the field of cardiac monitoring are leading to technological expansion. This, in turn, is positively influencing the growth of the arrhythmia monitoring devices market. Wearable diagnostic patch by iRhythm Technologies, Inc., Zio, has led to symptomatic arrhythmia monitoring, which is superior in comparison to conventional Holter monitors.
Big pharma and medical device companies are heavily investing in R&D to perform a detailed mapping of cardiac arrhythmia. In February 2018, Medtronic received FDA clearance for the first non-invasive cardiac mapping system, CardioInsight. It includes wearable 252-electrode sensor vest that creates 3D electroanatomic maps of heart by combining data from a cardiac computed tomography scan with ECG signals collected from the chest region.
In addition to these technologies, emergence and advancements in mobile cardiac telemetry are leading to further progress of the overall market. In October 2017, Abbott received FDA clearance for Confirm Rx, a smartphone-compatible implantable cardiac monitor indicated for arrhythmia diagnosis. Boston Scientific announced its FDA approval for Resonate, a line of cardiac resynchronization therapy defibrillator and cardioverter defibrillator systems for the cardiac management.
Report Highlights
Based on type, the market is classified into ECG, implantable monitors, Holter monitors, and mobile cardiac telemetry. Of these, Holter monitors dominated the market in terms of revenue in 2020. These devices can be used for longer durations to diagnose sporadic symptoms in patients and they also offer faster and convenient monitoring to increase patient compliance and enhance treatment outcome.
Increasing research studies pertaining to development of arrhythmia monitoring devices are estimated to drive the market over the forthcoming years. Technologies such as rhythm strip generating smartphone devices by Cardiac Designs (ECG Check) and AliveCor (Kardia Mobile) have resulted in expansion of arrhythmia monitoring and wearable technology.
The mobile cardiac telemetry segment is anticipated to experience the fastest growth during the forecast period. These devices read cardiac rhythm with the help of external devices consisting of metal sensors. In addition, some of the monitoring functions offered by smartphones use photo-plethysmography through phone camera to detect atrial fibrillation. In a study published in December 2020, wireless ECG delivered a performance accuracy of 91.62% corresponding to hospital diagnostic standard while providing a portable monitoring.
Atrial fibrillation was the leading application segment in the arrhythmia monitoring devices market in terms of revenue in 2020. It is a common type of arrhythmia associated with a high risk of stroke and blood clotting. In many cases, it remains undiagnosed in clinical practices with conventional monitoring, resulting in inadequate treatment at the right time. Therefore, monitoring of atrial fibrillation requires enhanced technological devices for diagnosis that can help overcome limitations imposed by conventional technologies.
In recent years, innovative smartphone applications have been introduced for arrhythmic patients that can connect them with healthcare professionals. Moreover, hospitals and clinical settings are taking initiatives to involve arrhythmia care in their treatment routine. In May 2018, UNC AFib Care Network launched a new clinic for atrial fibrillation patients - AFib Integrated Care Clinic.
Hospitals and clinics were the leading end users of arrhythmia monitoring devices in 2020. Tremendous research and technological advancements in the field and rising number of geriatric patients suffering from cardiac disorders are contributing to the growth of the segment. In a study published in April 2018, it was observed that daily short-term rhythm strip recordings identified an increase of 13.0% in elderly population hospitalized for atrial fibrillation, leading to an overall prevalence of 46.0% in hospitalized patients.
A novel imaging technique, developed by an international team of researchers of the Heart Center at the University Medical Center Göttingen and Max Planck Institute for Dynamics and Self-Organization, is projected to help physicians at hospitals to identify heart rhythm disorders in the coming years. The new diagnostic method is poised to assist in treatment of ventricular fibrillation and atrial fibrillation.
North America was at the forefront of the global arena in 2020 due to rising FDA approval for arrhythmic monitoring devices. Manufacturers of medical devices are continually investing in R&D activities of monitoring devices leading to a constant improvement in the monitoring and diagnostic technology.
Icentia, a Canadian manufacturer of medical devices, launched CardioSTAT which provided comfortable ECG recording for up to seven days. The device became an essential tool for detection of heart rhythm disorders across the country. In 2020, the company launched a new version of CardioSTAT which had an extended recording duration for more accurate and definitive diagnosis, especially, with patients suffering from paroxysmal atrial fibrillation (AF).
Key Players
AliveCor, Inc.; Applied Cardiac Systems; BioTelemetry, Inc.; BIOTRONIK; FU.K.uda Denshi Co., Ltd.; GE Healthcare; iRhythm; Medi-Lynx; St. Jude Medical (Abbott); Medtronic; Nihon Kohden Corporation; Nuubo; and Spacelabs Healthcare.
Market Segmentation
Type Outlook
ECG
Implantable Monitors
Holter Monitors
Mobile Cardiac Telemetry
Application Outlook
Bradycardia
Tachycardia
Atrial Fibrillation
Ventricular Fibrillation
Premature Contraction
Others
End-use Outlook
Hospitals & Clinics
Diagnostic Centers
Others
Regional Outlook
North America
The U.S.
Canada
Europe
The U.K.
Germany
France
Italy
Spain
Asia Pacific
Japan
China
India
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
The Arrhythmia Monitoring Devices market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.
The report provides size (in terms of volume and value) of Arrhythmia Monitoring Devices market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
This report focuses on the global Arrhythmia Monitoring Devices market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Arrhythmia Monitoring Devices market development in United States, Europe and China.
It is pertinent to consider that in a volatile global economy, we haven’t just conducted Arrhythmia Monitoring Devices market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.
In terms of production side, this report researches the Arrhythmia Monitoring Devices capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.
In terms of consumption side, this report focuses on the consumption of Arrhythmia Monitoring Devices by regions (countries) and application.
Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Arrhythmia Monitoring Devices market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.
With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Arrhythmia Monitoring Devices market companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Arrhythmia Monitoring Devices market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.
Overall, this is an in-depth research report specifically for the Arrhythmia Monitoring Devices industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.
The Arrhythmia Monitoring Devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Arrhythmia Monitoring Devices market.
Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Arrhythmia Monitoring Devices market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.
Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Arrhythmia Monitoring Devices market. These factors have benefited the growth of the global market for Arrhythmia Monitoring Devices. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.
New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Arrhythmia Monitoring Devices. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).
In this study, the years considered to estimate the market size of Arrhythmia Monitoring Devices are as follows:
Reasons to Purchase this Report:
- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.
Market Size Estimation
Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).
The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.
Market Breakdown and Data Triangulation
After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.
Secondary Sources
Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.
Primary Sources
In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.
The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.
The study objectives of this report are:
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Arrhythmia Monitoring Devices Market, By Type
7.1. Arrhythmia Monitoring Devices Market, By Type, 2021-2028
7.1.1. ECG
7.1.1.1. Market Revenue and Forecast (2016-2028)
7.1.2. Implantable Monitors
7.1.2.1. Market Revenue and Forecast (2016-2028)
7.1.3. Holter Monitors
7.1.3.1. Market Revenue and Forecast (2016-2028)
7.1.4. Mobile Cardiac Telemetry
7.1.4.1. Market Revenue and Forecast (2016-2028)
Chapter 8. Global Arrhythmia Monitoring Devices Market, By Application
8.1. Arrhythmia Monitoring Devices Market, by Application, 2021-2028
8.1.1. Bradycardia
8.1.1.1. Market Revenue and Forecast (2016-2028)
8.1.2. Tachycardia
8.1.2.1. Market Revenue and Forecast (2016-2028)
8.1.3. Atrial Fibrillation
8.1.3.1. Market Revenue and Forecast (2016-2028)
8.1.4. Ventricular Fibrillation
8.1.4.1. Market Revenue and Forecast (2016-2028)
8.1.5. Premature Contraction
8.1.5.1. Market Revenue and Forecast (2016-2028)
Chapter 9. Global Arrhythmia Monitoring Devices Market, By End User
9.1. Arrhythmia Monitoring Devices Market, by End User, 2021-2028
9.1.1. Hospitals & Clinics
9.1.1.1. Market Revenue and Forecast (2016-2028)
9.1.2. Diagnostic Centers
9.1.2.1. Market Revenue and Forecast (2016-2028)
Chapter 10. Global Arrhythmia Monitoring Devices Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.3. Market Revenue and Forecast, by End User (2016-2028)
10.1.4. U.S.
10.1.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.1.5. Rest of North America
10.1.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.1.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.1.5.3. Market Revenue and Forecast, by End User (2016-2028)
10.2. Europe
10.2.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.3. Market Revenue and Forecast, by End User (2016-2028)
10.2.4. UK
10.2.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.2.5. Germany
10.2.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.5.3. Market Revenue and Forecast, by End User (2016-2028)
10.2.6. France
10.2.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.6.3. Market Revenue and Forecast, by End User (2016-2028)
10.2.7. Rest of Europe
10.2.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.2.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.2.7.3. Market Revenue and Forecast, by End User (2016-2028)
10.3. APAC
10.3.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.3. Market Revenue and Forecast, by End User (2016-2028)
10.3.4. India
10.3.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.3.5. China
10.3.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.5.3. Market Revenue and Forecast, by End User (2016-2028)
10.3.6. Japan
10.3.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.6.3. Market Revenue and Forecast, by End User (2016-2028)
10.3.7. Rest of APAC
10.3.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.3.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.3.7.3. Market Revenue and Forecast, by End User (2016-2028)
10.4. MEA
10.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.4.4. GCC
10.4.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.4.5. North Africa
10.4.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.5.3. Market Revenue and Forecast, by End User (2016-2028)
10.4.6. South Africa
10.4.6.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.6.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.6.3. Market Revenue and Forecast, by End User (2016-2028)
10.4.7. Rest of MEA
10.4.7.1. Market Revenue and Forecast, By Type (2016-2028)
10.4.7.2. Market Revenue and Forecast, by Application (2016-2028)
10.4.7.3. Market Revenue and Forecast, by End User (2016-2028)
10.5. Latin America
10.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.3. Market Revenue and Forecast, by End User (2016-2028)
10.5.4. Brazil
10.5.4.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.4.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.4.3. Market Revenue and Forecast, by End User (2016-2028)
10.5.5. Rest of LATAM
10.5.5.1. Market Revenue and Forecast, By Type (2016-2028)
10.5.5.2. Market Revenue and Forecast, by Application (2016-2028)
10.5.5.3. Market Revenue and Forecast, by End User (2016-2028)
Chapter 11. Company Profiles
11.1. AliveCor, Inc.
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Applied Cardiac Systems
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. BioTelemetry, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. BIOTRONIK
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. Recent Initiatives
11.5. FU.K.uda Denshi Co., Ltd.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. GE Healthcare
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. iRhythm
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Medi-Lynx
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. St. Jude Medical (Abbott)
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. Medtronic
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
11.11. Nihon Kohden Corporation
11.11.1. Company Overview
11.11.2. Product Offerings
11.11.3. Financial Performance
11.11.4. Recent Initiatives
11.12. Nuubo
11.12.1. Company Overview
11.12.2. Product Offerings
11.12.3. Financial Performance
11.12.4. Recent Initiatives
11.13. Spacelabs Healthcare
11.13.1. Company Overview
11.13.2. Product Offerings
11.13.3. Financial Performance
11.13.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
Glossary of Terms